VIAP — VIA Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $13.92m
Annual balance sheet for VIA Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.34 | 23.1 | 4.07 | 2.19 | 0.084 |
Prepaid Expenses | |||||
Total Current Assets | 3.45 | 24.1 | 4.67 | 2.35 | 0.444 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.182 | 0.335 | 0.292 | 0.171 | 0.023 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3.73 | 24.5 | 5 | 2.56 | 0.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.59 | 3.93 | 3.41 | 13.7 | 19 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.6 | 3.93 | 3.44 | 13.8 | 19 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -5.87 | 20.6 | 1.56 | -11.2 | -18.5 |
Total Liabilities & Shareholders' Equity | 3.73 | 24.5 | 5 | 2.56 | 0.5 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |